Thursday, April 2, 2015

Fight Over High-Cost Drugs to Intensify After Catamaran Deal

Fight Over High-Cost Drugs to Intensify After Catamaran Deal
Bloomberg-Mar 30, 2015
Pharmacy benefit managers will also look for savings from “biosimilar” versions of expensive biotechnology drugs.

No comments: